Periodontitis and risk of diabetes mellitus

Journal of Diabetes

Volumn 3, Issue 1, 2011, Pages 21-28

  Gurav, Abhijit ^a   Jadhav, Varsha ^a  

^a Tatyasaheb Kore Dental College and Research Centre   (India)

Author keywords

Diabetes mellitus; Inflammation; Periodontitis

Indexed keywords

ADVANCED GLYCATION END PRODUCT; DOXYCYCLINE; INSULIN;

ANTIBIOTIC THERAPY; BACTERIAL INFECTION; CELL FUNCTION; DIABETES MELLITUS; GINGIVECTOMY; HUMAN; IMMUNOCOMPETENT CELL; NONHUMAN; PERIODONTITIS; PERIODONTIUM; PREVALENCE; PRIORITY JOURNAL; REVIEW; TOOTH EXTRACTION;

BACTERIAL INFECTIONS; DIABETES COMPLICATIONS; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; PERIODONTITIS; PERIODONTIUM; RISK FACTORS;

EID: 79951798135     PISSN: 17530393     EISSN: 17530407     Source Type: Journal    
DOI: 10.1111/j.1753-0407.2010.00098.x     Document Type: Review

References (101)

1. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: Prevalence, numerical estimates and projections. Diabetes Care. 1998; 21: 1414-31.
2. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: Estimates for the year 2000 and projections 2030. Diabetes Care. 2004; 27: 1047-53.
3. Page RC, Offenbacher S, Schroeder HE, Seymour JG, Kornman KS. Advances in the pathogenesis of periodontitis: Summary of developments, clinical implications and future directions. Periodontol 2000. 1997; 14: 216-48.
4. Papapanou PN. Epidemiology of periodontal diseases: An update. J Int Acad Periodontol. 1999; 1: 110-6.
5. American Academy of Periodontology. Diabetes and periodontal diseases (position paper). J Periodontol. 1999; 70: 935-49.
6. Sastrowijoto S, Hillemans P, van Steenbergen T, Abraham-Inpijn L, de Graaff J. Periodontal condition and microbiology of healthy and diseased periodontal pockets in Type 1 diabetes mellitus patients. J Clin Periodontol. 1989; 16: 316-22.
7. Loe H. Periodontal disease. The sixth complication of diabetes mellitus. Diabetes Care. 1993; 16: 329-34.
8. Zambon JJ, Reynolds H, Fisher JG, Shlossman M, Dunford R, Genco RJ. Microbiological and immunological studies of adult periodontitis in patients with non-insulin dependent diabetes mellitus. J Periodontol. 1988; 59: 23-31.
9. Manoucher PM, Spagnuolo PJ, Rodman HM, Bissada NF. Comparison of neutrophil chemotactic response in diabetic patients with mild and severe periodontal disease. J Periodontol. 1981; 52: 410-5.
10. McMullen JA, Van Dyke TE, Horoszewicz HU, Genco RJ. Neutrophil chemotaxis in individuals with advanced periodontal disease and a genetic predisposition to diabetes mellitus. J Periodontol. 1981; 52: 167-73.
11. Mealey BL, Ocampo GL. Diabetes mellitus and peridontal disease. Periodontol 2000. 2007; 44: 127-53.
12. Mealey B. Diabetes and periodontal diseases. J Periodontol. 1999; 70: 935-49.
13. Festa A, D'Agostino RDJ, Howard G, Mykkanen I, Tracy RP, Haffner SM. Chronic subclinical inflammation as apart of the insulin resistance syndrome. The insulin resistance atherosclerosis study (IRAS). Circulation. 2000; 102: 42-7.
14. Salvi GE, Collins JG, Yalda B, Arnold RR, Lang NP, Offenbacher S. Monocytic TNF-α secretion patterns in IDDM patients with periodontal diseases. J Clin Periodontol. 1997; 24: 8-16.
15. Naguib G, Al-Mashat H, Desta T, Graves D. Diabetes prolongs the inflammatory response to a bacterial stimulus through cytokine dysregulation. J Invest Dermatol. 2004; 123: 87-92.
16. Casazza JP, Veech RL. The measurement of xylulose 5-phosphate, ribulose 5-phosphate, and combined sedoheptulose 7-phosphate and ribose 5-phosphate in liver tissue. Anal Biochem. 1986; 159: 243-8.
17. 2, and NO, and antioxidant enzyme activities of rat neutrophils in culture. Cell Biochem Funct. 1998; 16: 43-9.
18. Bellavite P. The superoxide-forming enzymatic system of phagocytes. Free Radic Biol Med. 1988; 4: 225-61.
19. Cerillo A. Cardiovascular effects of acute hyperglycemia: Pathophysiological underpinnings. Diab Vasc Dis Res. 2008; 5: 260-8.
20. Spinetti G, Kraenkel N, Emanuuel C, Madeddu P. Diabetes and vessel wall remodelling: From mechanistic insights to regenerative therapies. Cardiovasc Res. 2008; 78: 265-73.
21. Costa Rosa LF, Safi DA, Cury Y, Curi R. The effect of insulin on macrophage metabolism and function. Cell Biochem Funct. 1996; 14: 33-42.
22. Otton R, Mendonça JR, Curi R. Diabetes causes marked changes in lymphocyte metabolism. J Endocrinol. 2002; 174: 55-61.
23. Gray GR, Stamatoyannopoulos G, Naiman SC et al. Neutrophil dysfunction, chronic granulomatous disease, and non-spherocytic haemolytic anaemia caused by complete deficiency of glucose-6-phosphate dehydrogenase. Lancet. 1973; 2: 530-4.
24. Roos D, van Zwieten R, Wijnen JT et al. Molecular basis and enzymatic properties of glucose 6-phosphate dehydrogenase volendam, leading to chronic nonspherocytic anemia, granulocyte dysfunction, and increased susceptibility to infections. Blood. 1999; 94: 2955-62.
25. Newsholme P, Lima MM, Procopio J et al. Glutamine and glutamate as vital metabolites. Braz J Med Biol Res. 2003; 36: 153-63.
26. Curi R, Lagranha CJ, Doi SQ et al. Molecular mechanisms of glutamine action. J Cell Physiol. 2005; 204: 392-401.
27. Ogle CK, Ogle JD, Mao JX et al. Effect of glutamine on phagocytosis and bacterial killing by normal and pediatric burn patient neutrophils. J Parenter Enteral Nutr. 1994; 18: 128-33.
28. Pithon-Curi TC, Schumacher RI, Freitas JJ et al. Glutamine delays spontaneous apoptosis in neutrophils. Am J Physiol Cell Physiol. 2003; 284: C1355-61.
29. Noritake M, Katsura Y, Shinomiya N et al. Intracellular hydrogen peroxide production by peripheral phagocytes from diabetic patients. Dissociation between polymorphonuclear leucocytes and monocytes. Clin Exp Immunol. 1992; 88: 269-74.
30. Inoue S, Lan Y, Muran J, Tsuji M. Reduced hydrogen peroxide production in neutrophils from patients with diabetes. Diabetes Res Clin Pract. 1996; 33: 119-27.
31. Alba-Loureiro TC, Hirabara SM, Mendonça JR, Curi R, Pithon-Curi TC. Diabetes causes marked changes in function and metabolism of rat neutrophils. J Endocrinol. 2006; 188: 295-303.
32. Yoshikawa T, Yoshida N, Manabe H, Terasawa Y, Takemura T, Kondo M. alpha-Tocopherol protects against expression of adhesion molecules on neutrophils and endothelial cells. Biofactors. 1998; 7: 9-15.
33. Mohanty P, Hamouda W, Garg R, Aljada A, Ghanim H, Dandona P. Hyperglycemia, as in diabetes stimulates reactive oxygen species (ROS) generation by leucocytes. J Clin Endocrinol Metab. 2000; 8: 2970-3.
34. Aljada A, Friedman J, Ghanim H et al. Glucose ingestion induces an increase in intranuclear nuclear factor kappa B, a fall in cellular inhibitor kappa B, and an increase in tumor necrosis factor alpha messenger RNA by mononuclear cells in healthy human subjects. Metabolism. 2006; 55: 1177-85.
35. Chapple IL, Matthews JB. The role of reactive oxygen species (ROS) and antioxidant species in periodontal tissue destruction. Periodontol 2000. 2007; 43: 160-232.
36. Valko M, Leibfritz D, Moncol J, Cronin MTD, Mazur M, Joshua T. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007; 39: 44-84.
37. Valko M, Morris H, Cronin MT. Metals toxicity and oxidative stress. Curr Med Chem. 2005; 12: 1161-208.
38. Sugano N, Kawamoto K, Numazaki H, Murai S, Ito K. Detection of mitochondrial DNA mutations in human gingival tissues. J Oral Sci. 2000; 42: 221-3.
39. Takane M, Sugano N, Iwasaki H, Iwano Y, Shimizu N, Ito K. New biomarker evidence of oxidative DNA damage in whole saliva from clinically healthy and periodontally diseased individuals. J Periodontol. 2002; 73: 551-4.
40. Sculley DV, Langley-Evans SC. Periodontal disease is associated with lower antioxidant capacity in whole saliva and evidence of increased protein oxidation. Clin Sci. 2003; 105: 167-72.
41. Panjamurthy K, Manoharan S, Ramachandran CR. Lipid peroxidation and antioxidant status in patients with periodontitis. Cell Mol Biol Lett. 2005; 10: 255-64.
42. Al-Mubarak S, Ciancio S, Aljada A, Mohanty P, Ross C, Dandona P. Comparative evaluation of adjunctive oral irrigation in diabetics. J Clin Periodontol. 2002; 29: 295-300.
43. Sakallioglu EE, Ayas B, Lutfioglu M, Keles GC, Acikgoz G, Firatli E. Gingival levels of monocyte chemoattractant protein-1 (MCP-1) in diabetes mellitus and periodontitis: An experimental study in rats. Clin Oral Invest. 2008; 12: 83-9.
44. Emingil G, Atilla G, Huseyinov A. Gingival crevicular fluid monocyte chemoattractant protein-1 and RANTES levels in patients with generalized aggressive periodontitis. J Clin Periodontol. 2004; 31: 829-34.
45. Garlet GP, Martins W Jr, Ferreira BR, Milanezi CM, Silva JS. Patterns of chemokines and chemokine receptors expressionin different forms of human periodontal disease. J Periodontal Res. 2003; 38: 210-7.
46. Nomura S, Shouzu A, Omoto S, Nishikawa M, Fukuhara S. Significance of chemokines and activated platelets in patients with diabetes. Clin Exp Immunol. 2000; 121: 437-43.
47. Tashimo A, Mitamura Y, Nagai S et al. Aqueous levels of macrophage migration inhibitory factor and monocyte chemotactic protein-1 in patients with diabetic retinopathy. Diabet Med. 2004; 21: 1292-7.
48. Engebretson SP, Hey-Hadavi J, Ehrhardt FJ et al. Gingival crevicular fluid levels of interleukin 1β and glycemic control in patients with chronic periodontitis and Type 2 diabetes. J Periodontol. 2004; 75: 1203-8.
49. Salvi GE, Yalda B, Collins JG et al. Inflammatory mediator response as a potential risk marker for periodontal diseases in insulin-dependent diabetes mellitus patients. J Periodontol. 1997; 68: 127-35.
50. Willershausen-Zonnchen B, Lemmen C, Hamm G. Influence of high glucose concentrations on glycosaminoglycan and collagen synthesis in cultured human gingival fibroblasts. J Clin Periodontol. 1991; 18: 190-5.
51. Ramamurthy NS, Zebrowski EJ, Golub LM. Insulin reversal of alloxan-diabetes induced changes in gingival collagen metabolism of the rat. J Periodontal Res. 1974; 9: 199-206.
52. Brownlee M. Glycation and diabetic complications. Diabetes. 1994; 43: 836-41.
53. Monnier VM, Glomb M, Elgawish A, Sell DR. The mechanism of collagen cross linking in diabetes. A puzzle nearing resolution. Diabetes. 1996; 45: 67-72.
54. Golub LM, Lee HM, Ryan ME. Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms. Adv Dent Res. 1998; 12: 12-26.
55. Ryan M, Ramamurthy NS, Sorsa T, Golub LM. MMP mediated events in diabetes. Ann N Y Acad Sci. 1999; 878: 311-34.
56. Sorsa T, Ingman T, Suomalainen K et al. Cellular source and tetracycline inhibition of gingival crevicular fluid collagenase of patients with labile diabetes mellitus. J Clin Periodontol. 1992; 19: 146-9.
57. Monnier VM, Mustata GT, Biemel KL et al. Cross-linking of the extracellular matrix by the Maillard reaction in aging and diabetes: An update on "a puzzle nearing resolution". Ann N Y Acad Sci. 2005; 1043: 533-44.
58. Wang X, Shen X, Li X, Agrawal CM. Age-related changes in the collagen network and toughness of bone. Bone. 2002; 31: 1-7.
59. Vashisht D, Gibson GJ, Khoury JI, Schaffler MB, Kimura J, Fyhrie DP. Influence of nonenzymatic glycation on biomechanical properties of cortical bone. Bone. 2001; 28: 195-201.
60. Verzijl N, DeGroot J, Ben ZC et al. Crosslinking by advanced glycation end products increases the stiffness of the collagen network in human articular cartilage: A possible mechanism through which age is a risk factor for osteoarthritis. Arthritis Rheum. 2002; 46: 114-23.
61. Gunczler P, Lanes R, Paoli M, Martinis R, Villaroel O, Weisinger JR. Decreased bone mineral density and bone formation markers shortly after diagnosis of clinical Type 1 diabetes mellitus. J Pediatr Endocrinol Metab. 2001; 14: 525-8.
62. McCarthy AD, Etcheverry SB, Bruzzone L, Lettierri G, Barrio DA, Cortizo AM. Non-enzymatic glycosylation of a type I collagen matrix: Effects on osteoblastic development and oxidative stress. BMC Cell Biol. 2001; 2: 16-21.
63. Santana RB, Xu L, Chase HB, Amar S, Graves DT, Trackman PC. A role for advanced glycation end products in diminished bone healing in Type 1 diabetes. Diabetes. 2003; 52: 1502-10.
64. Takagi M, Kasayama S, Yamamoto T et al. Advanced glycation end products stimulate interleukin-6 production by human bone-derived cells. J Bone Miner Res. 1997; 12: 439-46.
65. Valerio G, del Puente A, Esposito-del Puente A et al. Increased urinary excretion of collagen cross links in Type 1 diabetic children in the first 5years of disease. Horm Res. 1999; 51: 173-7.
66. Okazaki R, Totsuka Y, Hamano K et al. Metabolic improvement of poorly controlled noninsulin-dependent diabetes mellitus decreases bone turnover. J Clin Endocrinol Metab. 1997; 82: 2915-20.
67. Okazaki R, Miura M, Toriumi M et al. Short-term treatment with troglitazone decreases bone turnover in patients with Type 2 diabetes mellitus. Endocr J. 1999; 46: 795-801.
68. Erbagci AB, Araz M, Ergabci A, Tarakcioglu M, Namiduru ES. Serum prolidase activity as a marker of osteoporosis in Type 2 diabetes mellitus. Clin Biochem. 2002; 35: 263-8.
69. Cloos C, Wahl P, Hasslacher C et al. Urinary glycosylated, free and total pyridinolines and free and total deoxypyridinoline in diabetes mellitus. Clin Endocrinol. 1998; 48: 317-23.
70. Schmidt AM, Hori O, Brett J, Yan SD, Wautier JL, Stren D. Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. Atheroscler Thromb. 1994; 14: 1521-8.
71. Vlassara H, Bucala R. Recent progress in advanced glycation and diabetic vascular disease: Role of advanced glycation end product receptors. Diabetes. 1996; 45: 65-6.
72. Schmidt AM, Hori O, Cao R et al. RAGE: A novel cellular receptor for advanced glycation end products. Diabetes. 1996; 45: 77-80.
73. Paques M, Massin P, Gaudric A. Growth factors and diabetic retinopathy. Diabetes Metab. 1997; 23: 125-30.
74. Chiarelli F, Santilli F, Mohn A. Role of growth factors in the development of diabetic complications. Horm Res. 2000; 53: 53-67.
75. Unlu F, Gurdal Guneri P, Hekimgil M, Yesilbek B, Boyacioglu H. Expression of vascular endothelial growth factor in human periodontal tissues: Comparison of healthy and diabetic patients. J Periodontol. 2003; 74: 181-7.
76. Graves DT, Liu R, Oates TW. Diabetes-enhanced inflammation and apoptosis: Impact on periodontal pathosis. Periodontol 2000. 2007; 45: 128-37.
77. Ohnishi T, Bandow K, Kakimoto K, Machigashira M, Matsuyama T, Matsuguchi T. Oxidative stress causes alveolar bone loss in metabolic syndrome model mice with Type 2 diabetes. J Periodontal Res. 2009; 44: 43-51.
78. Genco RJ, Grossi SG, Ho A, Nishimura F, Murayama Y. A proposed model linking inflammation to obesity, diabetes and periodontal infections. J Periodontol. 2005; 76: 2075-84.
79. D'Aituo F, Parkar M, Andreou G et al. Periodontitis and systemic inflammation: Control of the local infection is associated with a reduction in serum inflammatory markers. J Dent Res. 2004; 83: 156-60.
80. Williams RC Jr, Mahan CJ. Periodontal disease and diabetes in young adults. JAMA. 1960; 172: 776-8.
81. Taylor GW, Burt BA, Becker MP et al. Severe periodontitis and risk for poor glycemic control in patients with non-insulin-dependent diabetes mellitus. J Periodontol. 1996; 67: 1085-93.
82. Grossi SG, Skrepcinski FB, Decaro T, Zambon JJ, Cummins D, Genco RJ. Response to periodontal therapy in diabetics and smokers. J Periodontol. 1996; 67: 1094-102.
83. Miller LS, Manwell MA, Newbold D et al. The relationship between reduction in periodontal inflammation and diabetes control: A report of 9 cases. J Periodontol. 1992; 63: 843-8.
84. Kiran M, Arpak N, Unsal E, Erdogan MF. The effect of improved periodontal health on metabolic control in Type II diabetes mellitus. J Clin Periodontol. 2005; 32: 266-72.
85. Rodrigues DC, Tabe MJ, Novaes AB, Souza SL, Grisi MF. Effect of non-surgical periodontal therapy on glycemic control in patients with Type 2 diabetes mellitus. J Periodontol. 2003; 74: 1361-7.
86. Aldridge JP, Lester V, Watts TLP, Collins A, Viberti G, Wilson RF. Single blind studies of the effects of improved periodontal health on metabolic control in Type I diabetes mellitus. J Clin Periodontol. 1995; 22: 271-5.
87. Christgau M, Palitzsch KD, Schmalz G, Kreiner U, Frenzel S. Healing response to non surgical periodontal therapy in patients with diabetes mellitus: Clinical, microbiological, and immunological results. J Clin Periodontol. 1998; 25: 112-24.
88. Westfelt E, Rylander H, Blohme G, Jonasson P, Lindhe J. The effect of periodontal therapy in diabetics. Results after 5years. J Clin Periodontol. 1996; 23: 92-100.
89. Emrich LJ, Shlossman M, Genco RJ. Periodontal disease in non-insulin dependent diabetes mellitus. J Periodontol. 1991; 62: 123-31.
90. Shlossman M, Knowler WC, Pettitt DJ, Genco RJ. Type 2 diabetes mellitus and periodontal disease. J Am Dent Assoc. 1990; 121: 532-6.
91. Fernandes JK, Wiegand RE, Salinas CF et al. Periodontal disease status in Gullah African Americans with Type 2 diabetes living in South Carolina. J Periodontol. 2009; 80: 1062-8.
92. Mansour AA, Abd-Al-Sada N. Periodontal disease among diabetics in Iraq. Med Gen Med. 2005; 7: 2-8.
93. Silvestre FJ, Miralles L, Llambes F, Bautista D, Solá-Izquierdo E, Hernández-Mijares A. Type 1 diabetes mellitus and periodontal disease: Relationship to different clinical variables. Med Oral Patol Oral Cir Bucal. 2009; 14: 175-9.
94. Novaes AB Jr, Gutierrez FG, Novaes AB. Periodontal disease progression in Type II non-insulin-dependent diabetes mellitus patients (NIDDM). Part I: Probing pocket depth and clinical attachment. Braz Dent J. 1996; 7: 65-73.
95. Tomita NE, Chinellato LE, Pernambuco RA, Lauris JR, Franco LJ. Periodontal conditions and diabetes mellitus in the Japanese-Brazilian population. Rev Saude Publica. 2002; 36: 607-13 (in Portuguese).
96. Tsai C, Hayes C, Taylor GW. Glycemic control of Type 2 diabetes and severe periodontal disease in the U.S. adult population. Community Dent Oral Epidemiol. 2002; 30: 182-92.
97. Singh S, Kumar V, Kumar S, Subbappa A. The effect of periodontal therapy on glycemic control in patients with Type 2 diabetes mellitus: A randomized controlled clinical trial. Int J Diabetes Dev Ctries. 2008; 28: 38-44.
98. Shetty N, Thomas B, Ramesh A. Comparison of neutrophil functions in diabetic and healthy subjects with chronic generalized periodontitis. J Indian Soc Periodontol. 2008; 12: 41-4.
99. Chowdhary A, Gayatri GV, Mehta DS. Comparative analysis of GCF β glucuronidase level in diabetic and non diabetic patients with chronic periodontitis: A clinical biochemical study. J Indian Soc Periodontol. 2008; 12: 16-20.
100. Vinitha R, Khalid G, Kumar V, Vijay V, Snehalatha C, Ramchandran A. Periodontal diseases in Asian Indian diabetics: A study from southern India. Int J Diabetes Dev Ctries. 2001; 21: 129-31.
101. Anil S, Remani P, Vijayakumar T, Hari S. Cell mediated and humoral immune responses in diabetic patients with periodontitis. Oral Surg Oral Med Oral Pathol. 1990; 70: 44-8.